Daily Dose - Aug 3rd, 2026
Daily Dose |
View online
August 3, 2026
Samsung Biologics’ 2026 growth strategy on track with full plant utilization
The CDMO reported stable manufacturing operations across Plants 1 through 4 in South Korea, as the company expands its global footprint.
Read More
CordenPharma completes AmbioPharm acquisition to expand peptide manufacturing
The acquisition adds U.S. and China manufacturing capacity, expanding the CDMO’s global peptide active pharmaceutical ingredient network and supply chain flexibility.
Read More
Enzene launches biomanufacturing platform for local biologics production
The platform combines continuous manufacturing, technology transfer, and workforce training to help establish regional biomanufacturing capabilities.
Read More
